Antibodies to the coronavirus have been detected in all four volunteers who were administered the full vaccination course of the preparation developed by the Vektor State Research Center of Virology and Biotechnology, Svetlana Usova, head of the laboratory of the department of biological and technological control of the Vektor Research Center said in an interview with Channel One on Thursday, APA reports citing TASS.
According to her, the volunteers didn’t experience any serious adverse effects, complications on the part of the central nervous and cardiovascular systems, nor elevated body temperature. "That is, the volunteers are in good health. We did not observe any adverse effects. We did not observe any serious adverse effects. Everything was, let’s say, is, going along successfully," the researcher added.
The Vektor Center obtained a permit from Russia’s Healthcare Ministry on July 24 to conduct clinical trials of its vaccine on volunteers. The first volunteer was inoculated on July 27.